Ninth Circuit upholds QueerDoc subpoena
Analysis based on 8 articles · First reported Aug 14, 2026 · Last updated Aug 15, 2026
The ruling may increase legal and compliance costs for healthcare providers offering gender-affirming care, potentially affecting their operations and insurance. It could also signal a more favorable environment for government investigations in this area, impacting the broader healthcare sector.
A divided panel of the United States — United States Court of Appeals for the Ninth Circuit ruled that President Donald Trump's goal of ending gender-affirming care is not improper and cannot be the basis for quashing a subpoena issued by the United States — United States Department of Justice against QueerDoc, a telemedicine provider of gender-affirming care. The 2-1 decision, authored by Judge Carlos Bea and joined by Judge Daniel Bress, reversed a lower court ruling that had quashed the subpoena, sending the case back to the district court to consider other arguments. The subpoena seeks personnel files, billing documents, communications with drug manufacturers, and patient records related to puberty blockers and hormone therapy. The American Civil Liberties Union, representing QueerDoc, plans to continue fighting the subpoena. The ruling is the first by an appeals court on these subpoenas, which are part of a broader Justice Department investigation into healthcare fraud and align with Trump's executive orders restricting gender-affirming care.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard